141 related articles for article (PubMed ID: 33616707)
21. Intraindividual Comparison of
Kesch C; Vinsensia M; Radtke JP; Schlemmer HP; Heller M; Ellert E; Holland-Letz T; Duensing S; Grabe N; Afshar-Oromieh A; Wieczorek K; Schäfer M; Neels OC; Cardinale J; Kratochwil C; Hohenfellner M; Kopka K; Haberkorn U; Hadaschik BA; Giesel FL
J Nucl Med; 2017 Nov; 58(11):1805-1810. PubMed ID: 28473595
[No Abstract] [Full Text] [Related]
22. The Impact of Magnetic Resonance Imaging on Prediction of Extraprostatic Extension and Prostatectomy Outcome in Patients with Low-, Intermediate- and High-Risk Prostate Cancer: Try to Find a Standard.
Radtke JP; Hadaschik BA; Wolf MB; Freitag MT; Schwab C; Alt C; Roth W; Duensing S; Pahernik SA; Roethke MC; Schlemmer HP; Hohenfellner M; Teber D
J Endourol; 2015 Dec; 29(12):1396-405. PubMed ID: 26154571
[TBL] [Abstract][Full Text] [Related]
23. Multiparametric Magnetic Resonance Imaging Is an Independent Predictor of Salvage Radiotherapy Outcomes After Radical Prostatectomy.
Sharma V; Nehra A; Colicchia M; Westerman ME; Kawashima A; Froemming AT; Kwon ED; Mynderse LA; Karnes RJ
Eur Urol; 2018 Jun; 73(6):879-887. PubMed ID: 29195777
[TBL] [Abstract][Full Text] [Related]
24. Prognostic Implications of Multiparametric Magnetic Resonance Imaging and Concomitant Systematic Biopsy in Predicting Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer Patients Diagnosed with Magnetic Resonance Imaging-targeted Biopsy.
Gandaglia G; Ploussard G; Valerio M; Marra G; Moschini M; Martini A; Roumiguié M; Fossati N; Stabile A; Beauval JB; Malavaud B; Scuderi S; Barletta F; Afferi L; Rakauskas A; Gontero P; Mattei A; Montorsi F; Briganti A
Eur Urol Oncol; 2020 Dec; 3(6):739-747. PubMed ID: 32847747
[TBL] [Abstract][Full Text] [Related]
25. Accuracy of preoperative multiparametric magnetic resonance imaging for prediction of unfavorable pathology in patients with localized prostate cancer undergoing radical prostatectomy.
Lee H; Kim CK; Park BK; Sung HH; Han DH; Jeon HG; Jeong BC; Seo SI; Jeon SS; Choi HY; Lee HM
World J Urol; 2017 Jun; 35(6):929-934. PubMed ID: 27738805
[TBL] [Abstract][Full Text] [Related]
26. Role of multiparametric magnetic resonance imaging to predict postoperative Gleason score upgrading in prostate cancer with Gleason score 3 + 4.
Kim H; Kim JK; Hong SK; Jeong CW; Ku JH; Kwak C
World J Urol; 2021 Jun; 39(6):1825-1830. PubMed ID: 32869150
[TBL] [Abstract][Full Text] [Related]
27. Comparison of biparametric versus multiparametric prostate MRI for the detection of extracapsular extension and seminal vesicle invasion in biopsy naïve patients.
Caglic I; Sushentsev N; Shah N; Warren AY; Lamb BW; Barrett T
Eur J Radiol; 2021 Aug; 141():109804. PubMed ID: 34062473
[TBL] [Abstract][Full Text] [Related]
28. mEPE-score: a comprehensive grading system for predicting pathologic extraprostatic extension of prostate cancer at multiparametric magnetic resonance imaging.
Gatti M; Faletti R; Gentile F; Soncin E; Calleris G; Fornari A; Oderda M; Serafini A; Strazzarino GA; Vissio E; Bergamasco L; Cirillo S; Papotti MG; Gontero P; Fonio P
Eur Radiol; 2022 Jul; 32(7):4942-4953. PubMed ID: 35290508
[TBL] [Abstract][Full Text] [Related]
29. Detection of Individual Prostate Cancer Foci via Multiparametric Magnetic Resonance Imaging.
Johnson DC; Raman SS; Mirak SA; Kwan L; Bajgiran AM; Hsu W; Maehara CK; Ahuja P; Faiena I; Pooli A; Salmasi A; Sisk A; Felker ER; Lu DSK; Reiter RE
Eur Urol; 2019 May; 75(5):712-720. PubMed ID: 30509763
[TBL] [Abstract][Full Text] [Related]
30. Multiparametric magnetic resonance imaging for prostate cancer-a comparative study including radical prostatectomy specimens.
Toner L; Papa N; Perera M; Katelaris N; Weerakoon M; Chin K; Harewood L; Bolton DM; Lawrentschuk N
World J Urol; 2017 Jun; 35(6):935-941. PubMed ID: 27785560
[TBL] [Abstract][Full Text] [Related]
31. Detectability of prostate cancer in different parts of the gland with 3-Tesla multiparametric magnetic resonance imaging: correlation with whole-mount histopathology.
Ito K; Furuta A; Kido A; Teramoto Y; Akamatsu S; Terada N; Yamasaki T; Inoue T; Ogawa O; Kobayashi T
Int J Clin Oncol; 2020 Apr; 25(4):732-740. PubMed ID: 31792635
[TBL] [Abstract][Full Text] [Related]
32. Combining prostate health index and multiparametric magnetic resonance imaging may better predict extraprostatic extension after radical prostatectomy.
Huang YP; Lin TP; Shen SH; Cheng WM; Huang TH; Huang IS; Fan YH; Lin CC; Huang EYH; Chung HJ; Lu SH; Chang YH; Lin ATL; Huang WJ
J Chin Med Assoc; 2023 Jan; 86(1):52-56. PubMed ID: 36346752
[TBL] [Abstract][Full Text] [Related]
33. The predictive value of endorectal 3 Tesla multiparametric magnetic resonance imaging for extraprostatic extension in patients with low, intermediate and high risk prostate cancer.
Somford DM; Hamoen EH; Fütterer JJ; van Basten JP; Hulsbergen-van de Kaa CA; Vreuls W; van Oort IM; Vergunst H; Kiemeney LA; Barentsz JO; Witjes JA
J Urol; 2013 Nov; 190(5):1728-34. PubMed ID: 23680307
[TBL] [Abstract][Full Text] [Related]
34. The Role of Magnetic Resonance Image Guided Prostate Biopsy in Stratifying Men for Risk of Extracapsular Extension at Radical Prostatectomy.
Raskolnikov D; George AK; Rais-Bahrami S; Turkbey B; Siddiqui MM; Shakir NA; Okoro C; Rothwax JT; Walton-Diaz A; Sankineni S; Su D; Stamatakis L; Merino MJ; Choyke PL; Wood BJ; Pinto PA
J Urol; 2015 Jul; 194(1):105-111. PubMed ID: 25623751
[TBL] [Abstract][Full Text] [Related]
35. Effect of observation size and apparent diffusion coefficient (ADC) value in PI-RADS v2.1 assessment category 4 and 5 observations compared to adverse pathological outcomes.
Abreu-Gomez J; Walker D; Alotaibi T; McInnes MDF; Flood TA; Schieda N
Eur Radiol; 2020 Aug; 30(8):4251-4261. PubMed ID: 32211965
[TBL] [Abstract][Full Text] [Related]
36. Predicting Pathological Tumor Size in Prostate Cancer Based on Multiparametric Prostate Magnetic Resonance Imaging and Preoperative Findings.
Pooli A; Johnson DC; Shirk J; Markovic D; Sadun TY; Sisk AE; Mohammadian Bajgiran A; Afshari Mirak S; Felker ER; Hughes AK; Raman SS; Reiter RE
J Urol; 2021 Feb; 205(2):444-451. PubMed ID: 33026934
[TBL] [Abstract][Full Text] [Related]
37. Combination of multiparametric magnetic resonance imaging and transrectal ultrasound-guided prostate biopsies is not enough for identifying patients eligible for hemiablative focal therapy for prostate cancer.
Choi YH; Yu JW; Kang MY; Sung HH; Jeong BC; Seo SI; Jeon SS; Lee HM; Jeon HG
World J Urol; 2019 Oct; 37(10):2129-2135. PubMed ID: 30603783
[TBL] [Abstract][Full Text] [Related]
38. A negative multiparametric magnetic resonance imaging finding does not guarantee the absence of significant cancer among biopsy-proven prostate cancer patients: a real-life clinical experience.
Kim JJ; Byun SS; Lee SE; Lee HJ; Choe G; Hong SK
Int Urol Nephrol; 2018 Nov; 50(11):1989-1997. PubMed ID: 30229465
[TBL] [Abstract][Full Text] [Related]
39. Development and internal validation of a side-specific, multiparametric magnetic resonance imaging-based nomogram for the prediction of extracapsular extension of prostate cancer.
Martini A; Gupta A; Lewis SC; Cumarasamy S; Haines KG; Briganti A; Montorsi F; Tewari AK
BJU Int; 2018 Dec; 122(6):1025-1033. PubMed ID: 29676063
[TBL] [Abstract][Full Text] [Related]
40. In-parallel comparative evaluation between multiparametric magnetic resonance imaging, prostate cancer antigen 3 and the prostate health index in predicting pathologically confirmed significant prostate cancer in men eligible for active surveillance.
Porpiglia F; Cantiello F; De Luca S; Manfredi M; Veltri A; Russo F; Sottile A; Damiano R
BJU Int; 2016 Oct; 118(4):527-34. PubMed ID: 26350955
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
